A role for urotensin II in restenosis following balloon angioplasty: use of a selective UT receptor blocker
Ewa Rakowski(Montreal General Hospital), Adel Giaid(Montreal General Hospital), Dashyant Dhanak(Wilmington University), Eliot H. Ohlstein(GlaxoSmithKline (United States)), Steven D. Douglas(Purdue University West Lafayette), Ghada S. Hassan(Université de Sherbrooke)
Cited by 59
Related Papers
The promise and peril of chemical probes
|Nature Chemical Biology|2015|848
Lymphocyte subsets in healthy children from birth through 18 years of age
|Journal of Allergy and Clinical Immunology|2003|828
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein‐coupled receptors
|British Journal of Pharmacology|2021|488
Chromatin proteins and modifications as drug targets
|Nature|2013|423
The Concise Guide to PHARMACOLOGY 2023/24: G protein-coupled receptors
|British Journal of Pharmacology|2023|390